However, in contrast with HSP90, PPIA levels did not change among groups, indicating that EV-enriched PPIA may not be useful for differential diagnosis of ALS from other diseases (Fig. 4d). This evidence concerns the gene HSP90AA1 and amyotrophic lateral sclerosis.